Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.43 +0.08 (+0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Return on Assets [ROA] (2014 - 2026)

Updated

Amphastar Pharmaceuticals' Return on Assets [ROA] was 4.63% in Q2 2026, down 3.68 percentage points from 8.31% a year earlier and down 0.20 percentage points from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Amphastar Pharmaceuticals came in at 6.12%, down 4.21 percentage points from FY2024.

  • Return on Assets [ROA] has now declined for three consecutive years, though with a five-year change of +5.94 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was 10.32% in FY2024 (-1.88 pp), 12.20% in FY2023 (-0.73 pp), 12.93% in FY2022 (+3.21 pp) and 9.72% in FY2021 (+9.54 pp).
  • The Q2 2026 figure marks the lowest quarterly Return on Assets [ROA] since Q2 2021.
  • Compared with a year earlier, Return on Assets [ROA] has declined for six straight quarters, with an average year-over-year change of -2.11 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2022 (a gain of 11.81 percentage points); the worst was Q4 2025 (a drop of 4.26 percentage points).
  • Per Business Quant data, AMPH's Return on Assets [ROA] in the three quarters before Q2 2026 was 4.83% (Q1 2026), 5.95% (Q4 2025) and 6.80% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Amphastar Pharmaceuticals 1.08 Bn -59.50 Mn 93.47 Mn 4.63%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.63%
Mar 31, 2026 4.83%
Dec 31, 2025 5.95%
Sep 30, 2025 6.80%
Jun 30, 2025 8.31%
Mar 31, 2025 8.84%
Dec 31, 2024 10.22%
Sep 30, 2024 10.39%
Jun 30, 2024 10.86%
Mar 31, 2024 10.02%
Dec 31, 2023 9.00%
Sep 30, 2023 9.26%
Jun 30, 2023 9.47%
Mar 31, 2023 12.29%
Dec 31, 2022 12.44%
Sep 30, 2022 10.65%
Jun 30, 2022 12.82%
Mar 31, 2022 12.05%
Dec 31, 2021 9.57%
Sep 30, 2021 5.73%
API Access

Amphastar Pharmaceuticals Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AMPH&period=max&api_key=YOUR_API_KEY